Email

razavi@bcm.edu

Positions

Associate Professor

Medicine-Cardiology
Baylor College of Medicine
Houston, TX US

Addresses

O'Quinn Medical Tower (Clinic)

6624 Fannin, #2480
Houston, TX 77030
United States
Phone: (713) 798-5570

O'Quinn Medical Tower (Office)

6624 Fannin, #2480
Houston, TX 77030
United States
Phone: (713) 798-5570

Clear Lake (Clinic)

450 Medical Center Blvd., Ste. 510
Webster, TX 77598
United States
Phone: (713) 798-5570

CHI St. Luke's Health (Hospital)

6720 Bertner Ave.
Houston, TX 77030
United States
Phone: (832) 355-1000

HCA Houston Healthcare Medical Center (Hospital)

1313 Hermann Dr.
Houston, TX 77004
United States
Phone: (713) 527-5000

HCA Healthcare Clear Lake Hospital (Hospital)

500 W. Medical Center Blvd.
Webster, TX 77598
United States
Phone: (281) 332-2511

Education

MD from Medical College Of Pennsylvania

01/1995 - Philadelphia, Pennsylvania United States

Residency at Mayo Graduate School of Medicine

01/1998 - Rochester, Minnesota United States

Internal Medicine

Fellowship at Mayo Graduate School of Medicine

01/2002 - Rochester, Minnesota United States

Electrophysiology Fellow, Cardiovascular Fellow

Certifications

American Board of Internal Medicine

Internal Medicine

American Board of Internal Medicine

Cardiovascular Disease

American Board of Internal Medicine

Clinical Cardiac Electrophysiology

Honors & Awards

Pfizer Award for Outstanding Clinical Fellow

North American Society of Pacing and Electrophysiology (NASPE) (01/2002)

Robert J. Hall Outstanding Cardiology Faculty Teaching Award

Voted outstanding teacher by general cardiology fellows at Texas Heart Institute.

Texas Heart Institute (07/2005 - 06/2006)

Robert J. Hall Outstanding Cardiology Faculty Teaching Award

Voted outstanding teacher by general cardiology fellows at Texas Heart Institute.

Texas Heart Institute (07/2012 - 06/2013)

Professional Statement

Dr. Mehdi Razavi joined Hall-Garcia Cardiology Associates in 2004. He attended medical school at the Medical College of Pennsylvania. He subsequently completed his residency, cardiology fellowship, and electrophysiology fellowship at the Mayo Clinic in Rochester, Minnesota. He was an Associate Professor of Medicine at Penn State University School of Medicine for one year prior to moving to Houston where he holds the same title at Baylor College of Medicine. He is also a Research Scientist at the Texas Heart Institute. Over the last two years he has been the lead or senior author of five manuscripts published in peer-reviewed journals in the field of cardiac electrophysiology. He recently received the Outstanding Faculty Award at Texas Heart Institute. Dr. Razavi has authored a textbook chapter on the mechanisms of sudden cardiac death and has given many presentations in the field of pharmacological treatment of arrhythmias. Dr. Razavi is involved with numerous clinical trials assessing the efficacy of cutting edge technology in the field of cardiac electrophysiology. Dr. Razavi is Board Certified in Cardiology and Cardiac Electrophysiology.

Websites

Selected Publications

• Thomson HL, Basmadjian AJ, Rainbird AJ, Razavi M, Avierinos JF, Pellikka PA, Bailey KR, Breen JF, Enriquez-Sarano M. "Contrast echocardiography improves the accuracy and reproducibility of left ventricular remodeling measurements: a prospective, randomly assigned, blinded study.." 2001 Sep;38(3):867-75. Pubmed PMID: 11527647
• Razavi M, Cheng J, Rasekh A, Yang D, Delapasse S, Ai T, Meade T, Donsky A, Goodman MJ, Massumi A "Slow pathway ablation decreases vulnerability to pacing-induced atrial fibrillation: Possible role of vagal denervation.." Pacing Clin Electrophysiol. 2006 Nov;29(11):1234-9. Pubmed PMID: 17100676
• Shuraih M, Ai T, Vatta M, Sohma Y, Merkle EM, Taylor E, Li Z, Xi Y, Razavi M, Towbin JA, Cheng J "A common SCN5A variant alters the responsiveness of human sodium channels to class I antiarrhythmic agents.." J. Cardiovasc. Electrophysiol.. 2007 Apr;18(4):434-40. Pubmed PMID: 17331104
• Barekatain A, Razavi M "Antiarrhythmic therapy in atrial fibrillation: indications, guidelines, and safety.." Tex Heart Inst J. 2012;39(4):532-4. Pubmed PMID: 22949771

Memberships

American College of Cardiology

Fellow

Association of Pakistani Physicians of North America

Member

Cardiac Electrophysiologic Society

Member

Funding

American Heart Association Collaborative Research Award

$750,000.00 (07/01/2015 - 06/01/2018)

Grant funding from American Heart Association

Collaboration with Rice University Department of Chemical Engineering to study the use of carbon nanotube fibers for reconstitution of delay electrical cardiac conduction in diseased myocardium.

Intellectual Property

Product Patent #9095262 (Approved)

An embodiment of the invention includes a system for the guidance of a catheter to different regions of tissue (e.g., cardiac tissue) for therapy (e.g., ablation therapy). A plurality of electrodes, such as an array of electrodes, may be configured to perform various tasks. First, some electrodes may measure cardiac polarization. Second, some electrodes may function as magnets (e.g., electromagnets) that guide a separate ablation catheter towards the electromagnetic electrodes. These electromagnetic electrodes may be positioned adjacent tissue that is now recognized (possibly due to the electrodes that measure cardiac polarization) as being in need of ablation therapy. Thus, the electromagnetic electrodes may cooperate with an ablation catheter to render a system with magnetic guidance capabilities using intracardiac magnetic field generation. The system may control electromagnetic forces from the array of electrodes to guide the ablation catheter tip to the desired therapy location.

Co Inventors: Alex Arevalos, Alan Brewer

Product Patent #7877144 (Approved)

Methods for optimizing the atrio-ventricular (A-V) delay for efficacious delivery of cardiac resynchronization therapy. In CRT devices, the programmed A-V delay starts with detection of electrical activity in the right atrium (RA). Thus, a major component of the A-V delay is the time required for inter-atrial conduction time (IACT) from the RA to the LA. This IACT can be measured during implantation as the time from the atrial lead stimulation artifact to local electrograms in a coronary sinus (CS) catheter. Assuming that the beginning of LA contraction closely corresponds with the beginning of LA electrical activity, the optimal AV delay should be related to the time between the start of RA electrical activity and the start of LA electrical activity plus the duration of LA atrial contraction. Thus ‘during atrial pacing’ the IACT measured at implantation is correlated with the echocardiographically defined optimal paced AV delay (PAV).

Co Inventors: Vadim Levin

Product Patent #8273023 (Approved)

An apparatus comprises a sheathe for introducing a catheter into a blood vessel, a first electrode provided on the sheathe, a second electrode; and a measuring device to which the first and second electrodes are coupled. The measuring device measures the impedance or conduction velocity between the first electrode on the sheathe and the second electrode.

Product Patent #8366615 (Approved)

An apparatus comprises a sheath for introducing a catheter into a blood vessel, at least one electrode provided on the sheath, at least one other electrode; and a measuring device to which at least one pair of electrodes are coupled. The measuring device measures the impedance or conduction velocity between the first electrode on the sheath and the second electrode.

Languages

Farsi